Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.61
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
4.31
-6.51%
Pre-market: Aug 15, 2025, 09:11 AM EDT
Vivos Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.02M | 3.7M | 3.86M | 4.05M | 3.42M | 3.25M | 3.3M | 3.4M | 3.86M | 3.95M | 4.25M | 4.18M | 3.46M | 4.39M | 4.55M | 4.5M | 3.45M |
Cost of Revenue | 1.51M | 1.6M | 1.53M | 1.4M | 1.48M | 1.46M | 1.4M | 1.3M | 1.52M | 1.57M | 1.75M | 1.6M | 1.09M | 1.29M | 1.36M | 872.65K | 758K |
Gross Profit | 1.51M | 2.1M | 2.33M | 2.65M | 1.94M | 1.79M | 1.9M | 2.1M | 2.34M | 2.38M | 2.5M | 2.59M | 2.37M | 3.11M | 3.18M | 3.62M | 2.69M |
Operating Income | -3.74M | -2.81M | -2.65M | -1.94M | -3.64M | -4.28M | -3.49M | -4.52M | -5M | -6.06M | -5.41M | -6.96M | -6.82M | -6.5M | -5.5M | -4.06M | -3.41M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31.46K | 58.82K | 18.97K | 7.75K |
Pretax Income | -3.86M | -2.83M | -2.62M | -1.93M | -3.76M | -4.26M | -2.09M | -5.53M | -1.7M | -6.09M | -5.43M | -6.99M | -5.51M | -7.39M | -5.45M | -4.04M | -3.4M |
Net Income | -3.86M | -2.83M | -2.62M | -1.93M | -3.76M | -4.26M | -2.09M | -5.53M | 4.77M | -7.3M | -5.46M | -7.02M | -4.21M | -20.27M | -5.45M | -4.04M | -3.4M |
Selling & General & Admin | 5.25M | 4.76M | 4.83M | 4.44M | 5.58M | 6.07M | 5.24M | 6.47M | 7.17M | 8.28M | 7.73M | 9.39M | 9.03M | 9.44M | 8.49M | 7.49M | 5.92M |
Research & Development | n/a | 100K | n/a | n/a | 100K | 100K | 100K | 100K | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | 146K | 145K | 22K | 5K | n/a | n/a | 175K | 169K | 175K | n/a | 162K | 168.23K | 192.5K | 194.77K | 177.5K |
Operating Expenses | 5.25M | 4.86M | 4.98M | 4.44M | 5.58M | 6.07M | 5.39M | 6.62M | 7.34M | 8.45M | 7.9M | 9.55M | 9.19M | 9.61M | 8.69M | 7.69M | 6.1M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 3.3M | n/a | n/a | n/a | 26K | 27K | 28K | n/a | 4.18K | 9.49K | 251.00 | 82.00 |
Selling & Marketing Expenses | 358K | 412K | 346K | 320K | 655K | 606K | 641K | 590K | 630K | 1.35M | 1.11M | 1.7M | 753K | 1.32M | 1.98M | 1.4M | 860.16K |
Cost & Expenses | 6.76M | 6.5M | 6.5M | 5.99M | 7.06M | 7.53M | 6.79M | 7.91M | 8.86M | 10.01M | 9.65M | 11.15M | 10.28M | 10.89M | 10.05M | 8.56M | 6.85M |
Income Tax Expense | n/a | n/a | n/a | n/a | 1.44M | n/a | n/a | n/a | -6.48M | 1.21M | 27K | 28K | -1.31M | 12.88M | -49.34K | -18.72K | -7.66K |
Shares Outstanding (Basic) | 8.6M | 5.89M | 6.62M | 3.23M | 2.31M | 1.83M | 1.2M | 1.2M | 990.56K | 920.48K | 849.34K | 849.34K | 849.32K | 920.48K | 833.06K | 829.52K | 728.42K |
Shares Outstanding (Diluted) | 8.6M | 5.89M | 6.62M | 3.23M | 2.31M | 1.83M | 1.2M | 1.2M | 990.56K | 920.48K | 849.34K | 849.34K | 849.34K | 921.26K | 833.06K | 829.52K | 728.44K |
EPS (Basic) | -0.45 | 1.26 | -0.4 | -0.6 | -1.63 | -2.32 | -1.75 | -4.62 | 4.82 | -7.93 | -6.43 | -8.27 | -4.95 | -22.02 | -6.55 | -4.87 | -4.67 |
EPS (Diluted) | -0.45 | 1.26 | -0.4 | -0.6 | -1.63 | -2.32 | -1.75 | -4.62 | 4.82 | -7.93 | -6.43 | -8.27 | -4.95 | -22 | -6.55 | -4.87 | -4.67 |
EBITDA | -3.56M | -2.66M | -2.5M | -1.79M | -3.64M | -4.11M | -3.49M | -4.37M | -4.83M | -5.92M | -5.23M | -6.68M | -6.48M | -7.22M | -5.25M | -3.87M | -3.22M |
EBIT | -3.74M | -2.83M | -2.65M | -1.94M | -3.79M | -4.28M | -3.49M | -4.52M | -5M | -4.88M | -5.41M | -6.96M | -6.64M | -7.39M | -5.5M | -4.06M | -3.41M |
Depreciation & Amortization | 177K | 144K | 146K | 145K | 146K | 149K | 150K | 148K | 175K | 169K | 175K | 162K | 162K | 168.23K | 192.5K | 194.77K | 177.5K |